The pharmaceutical company is redefining the future of healthcare in Malaysia to be more accessible and affordable while upholding its quality Sandoz, the global leader in developing off-patent generics and biosimilars, has recently taken a significant step by establishing a new regional talent hub in Kuala Lumpur, reinforcing its commitment to innovation and growth in the Asia-Pacific region. Founded by Kern & Sandoz in Switzerland in 1886, the company celebrates its dynamic and rich history during its first anniversary as a standalone company and stock-market listing this October. The company has been at the forefront of medical advancements with historical milestones including the launch of Calcium Sandoz in 1929, the introduction of the first oral penicillin in 1951, the first recombinant interferon alfa in 1980, and the world’s first biosimilar medicine in 2006. Today, the company stands out for delivering more than 800 million treatments to over 700 million patients every yea
.jpeg)
